Steve Bryson on Muck Rack

Steve Bryson

Verified
Canada
As seen in: Multiple Sclerosis News Today, Flipboard, NewsBreak, Parkinson's News Today, Alzheimer’s News Today, Pet News 2Day, ALS News Today, SMA News Today, Huntington's Disease News, Muscular Dystrophy News, Immuno-Oncology News and
Medical Science, Structural Biology, Science Writer, Musician, Cyclist 🖖 Views my own
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Steve

Contact Steve, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Kaftrio use not tied to activity gains in youths with cystic fibrosis

|
By Steve Bryson 
| Cystic Fibrosis News Today
Kaftrio (elexacaftor/tezacaftor/ivacaftor) use was not associated with additional improvements in physical activity among children and adolescents with cystic fibrosis (CF) in a small observational study. Even so, those who started Kaftrio during the study or were already receiving it showed improvements in some health-related quality-of-life domains, including treatment burden and respiratory symptoms.
Open in Who Shared Issue with article?

Six-month BW-20805 regimen cuts monthly HAE attack rates by up to 99%

|
By Steve Bryson 
| Angioedema News
A six-month dosing regimen of Argo Biopharma‘s long-acting investigational therapy BW-20805 reduced monthly attacks in people with hereditary angioedema (HAE) by up to 99%. That’s according to new data from an ongoing open-label Phase 2 clinical trial (NCT06846398) testing the therapy in up to 25 adults, ages 18-70, with HAE type 1 or type 2.
Open in Who Shared Issue with article?

VNS-tone pairing alters brain proteins in Rett syndrome rat model

|
By Steve Bryson 
| rettsyndromenews.com
Stimulating the vagus nerve, part of the autonomic nervous system that regulates involuntary functions, paired with sound tones, may support the development of future therapies for communication deficits in Rett syndrome.
Open in Who Shared Issue with article?
See all 6,437 articles

Actions

Share this page

Get in touch with Steve

Contact Steve, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified